Last reviewed · How we verify

NCT05304026

Optimizing CO2 Injection Technique for EVAR

Status unknown Last updated 31 March 2022
What this trial tests

trial testing Technique 1 in Abdominal Aortic Aneurysm in 30 participants. Status unknown.

Timeline
1 January 2021
Primary endpoint
1 June 2022
15 September 2022

Quick facts

Lead sponsorUniversity of Bologna
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment30
Start date1 January 2021
Primary completion1 June 2022
Estimated completion15 September 2022
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

University of Bologna

Who can join

Adults 18 to 100, any sex, with Abdominal Aortic Aneurysm or Endovascular Aortic Repair. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Automated carbon dioxide (CO2) angiography is considered a safe diagnostic alternative to standard iodinated contrast medium (ICM) for endovascular aortic repair (EVAR) of abdominal aortic aneurysm (AAA), especially in patients with preoperative renal function impairment. Recent literature experiences describe the use of automated CO2 angiography in EVAR. One of the main issues of CO2 angiography is the inability to detect the origin of the lowest renal artery (proximal neck visualization) that was estimated up to 38%. In these experiences, the CO2 automated angiography is usually performed by a 5F pigtail catheter placed at renal arteries level. The aim of the study is to evaluate the efficacy of a new automated CO2 injection technique by a 5F introducer (single hole catheter) positioned at the distal level of the proximal neck in detecting both renal arteries in the first diagnostic and completion angiographies.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Abdominal Aortic Aneurysm

Currently open trials in the same condition.

Other University of Bologna trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05304026.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing